Reference number of the aid programme: SA.41471(2015/X) Purpose of public aid: Article 25 of EC Regulation No 651/2014 of 17 June 2014 declaring certain types of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L. I'm sorry. EU L 187/1 of 26.06.2014). According to the Global Observatory on Donation and Transplantation, 119678 organs were transplanted worldwide in 2014 (1.65 % increase since 2013), representing less than 10 % of demand. In the United States, 121678 people are waiting for life-saving transplants (https://optn.transplant.hrsa.gov). In 2014. 4761 patients did not have a kidney transplant and 3668 were too ill for transplantation. Transplantologists face a deficit of organs, their poor condition, deteriorating during long-term transport. The problem is the lack of a solution allowing the long-term storage and transport of organs in close to physiological conditions (normothermia and supply of nutrients) and bulky and complex equipment. NanoSanguis S.A. has developed a groundbreaking concept of a system for long-term storage and transport of organs (the kidney, liver, heart) under physiological conditions that will solve the above problems. The system will extend the storage time of organs to up to 5 days, which could increase the coverage of global organ transplant demand to 25 %. The system consists of an organ perfusion fluid and an easy-to-transport device providing sterile conditions, organ perfusion, stable temperature and monitoring of the organ parameters. The company’s key know-how perfusion fluid, possessing the ability to supply oxygen and glucose, will preserve the good state of the collected organ and its regeneration. The system will enable comprehensive diagnosis of the organ before transplantation. This will increase the chances of adopting a body.